It is recommended that telmisartan be initiated at 40 mg/day with or without food; the dosage may be increased to up to 80 mg/day if further blood pressure reduction is needed.

The FDA has approved Widaplik, a polypill combining telmisartan, amlodipine, and indapamide, for the treatment of hypertension in adults, including as initial therapy. This is the first ...

Widaplik is a single tablet, triple combination therapy for hypertension that is expected to be available in the fourth quarter of 2025. The Food and Drug Administration (FDA) has approved Widaplik ™ ...

WIDAPLIK is a proprietary single pill combination of three medicines: telmisartan, amlodipine and indapamide and is available in three doses: a standard dose and two low doses.

Telmisartan and Hydrochlorothiazide(Micardis HCT) generic contains angiotensin II receptor blocker and diuretic, prescribed for high blood pressure.

Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomized, ...

Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, ...

Aim: Hearing loss, affecting a significant portion of the global population, is prevented with peroxisome proliferator-activated receptor γ agonism. Understanding potential protective treatments is ...

A new study suggests that a drug prescribed for high blood pressure may lower the risk of Alzheimer's disease, specifically in older Black adults.

Black people are almost twice as likely to develop Alzheimer's disease later in life than white people. Researchers report Telmisartan, a drug used to treat high blood pressure by blocking angiotensin ...